Peripheral Vascular Disease Pipeline Highlights - H2 2016 Update Report - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Peripheral Vascular Disease Pipeline Highlights - 2016 Update" drug pipelines to their offering.

Peripheral Vascular Disease Pipeline Highlights - 2016 Update, provides most up-to-date information on key pipeline products in the global Peripheral Vascular Disease market. It covers emerging therapies for Peripheral Vascular Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Scope of the Report

Clinical Trial Stages:

The report provides Peripheral Vascular Disease pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Peripheral Vascular Disease pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Peripheral Vascular Disease pipeline products by the company.

Short-term Launch Highlights:

Find out which Peripheral Vascular Disease pipeline products will be launched in the US and Ex-US till 2019.

Key Topics Covered:

1. Peripheral Vascular Disease Pipeline by Stages

2. Peripheral Vascular Disease Pipeline by Drug Class

3. Peripheral Vascular Disease Pipeline by Company

4. Peripheral Vascular Disease Phase 3 Clinical Trial Insights

5. Peripheral Vascular Disease Phase 2 Clinical Trial Insights

6. Peripheral Vascular Disease Phase 1 Clinical Trial Insights

7. Peripheral Vascular Disease Preclinical Research Insights

8. Peripheral Vascular Disease Discovery Stage Insights

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/ljfjj2/peripheral

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Drugs